Edgewise Therapeutics
Joanne Donovan serves as the Chief Medical Officer at Edgewise Therapeutics since April 2021 and has held the position of Physician at VA Boston Healthcare System since 1990. Prior to their current role, Joanne Donovan was Chief Medical Officer at Catabasis Pharmaceuticals, Inc. from 2011 to April 2021 and Vice President of Clinical Research at Genzyme from 1998 to 2011. Joanne Donovan holds a Doctor of Medicine (MD) degree from Harvard Medical School and a Doctor of Philosophy (PhD) in Medical Engineering/Medical Physics from the Massachusetts Institute of Technology.
This person is not in any teams
This person is not in any offices
Edgewise Therapeutics
1 followers
Edgewise Therapeutics is a biotechnology company harnessing proven expertise and understanding of skeletal muscle physiology to develop novel, transformative therapies for serious muscle diseases. Based in Boulder, Colorado, we have built a state-of-the-art muscle research facility to capitalize on new insights into the nature and consequences of muscle adaptation and injury with disease. Edgewise recently closed it’s Series B financing round which will support the advancement of Edgewise Therapeutic’s lead product candidate into clinical development for Duchenne and Becker Muscular Dystrophy (DMD and BMD) as well as expansion of the company’s pipeline. The company’s leadership team has founded multiple biotechnology startups, several of which have gone on to become publicly-traded companies and brings to bear a depth of experience in drug discovery, development and commercialization.